相关实验视频

Updated: Jan 10, 2026

In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes

In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes

Published on: June 10, 2021

基于iPSC的模型中的神经退行性疾病和自

Sodbileg Odonchimed¹, Keiko Imamura², Haruhisa Inoue²

¹Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan; Graduate School of Medicine, Kyoto University, Japan; RIKEN BioResource Research Center (BRC), Japan.

Neuroscience research

|November 28, 2025

概括

神经退行性疾病涉及神经元损失和蛋白质积累. 本综述探讨了在诱导多能干细胞 (iPSC) 模型中研究自如何有助于对这些疾病的理解和潜在治疗方法.

科学领域:

神经科学是一个神经科学.
细胞生物学细胞生物学
遗传学遗传学是一个

背景情况:

神经退行性疾病会导致神经元逐渐丧失,导致显著的运动,认知和行为缺陷.
错误折叠的蛋白质聚合物的积累是各种神经退行性疾病的关键病理特征.
自,一种细胞降解过程,对于维持蛋白质平衡至关重要,并且在这些疾病中经常失调.

研究的目的:

审查最近关于诱导多能干细胞 (iPSC) 基于神经退行性疾病模型的自的发现.
突出iPSC技术在研究疾病特异性自功能障碍方面的实用性.
探索针对神经退行性疾病中自的潜在治疗策略.

主要方法:

使用诱导多能干细胞 (iPSC) 技术生成患者特异的神经元模型.
研究iPSC衍生神经元中的自流和蛋白质聚合物清除.
在疾病模型中分析与自相关的遗传和分子途径.
审查已发表的关于基于iPSC的关于阿尔茨海默氏症,ALS和FTD中自的研究的文献.

主要成果:

iPSC模型总结了神经退行性疾病的关键特征,包括蛋白质聚合和自缺陷.
在不同的神经退行性疾病模型中,特定的自途径被确定为失调.
这些模型提供了对毒性蛋白质积聚背后的机制的见解.
有证据表明,调节自可以改善iPSC模型中的疾病表型.

结论:

基于iPSC的模型是剖析神经退行性疾病中自功能障碍的宝贵工具.
针对自是一种有希望的治疗途径,用于阿尔茨海默病,ALS和FTD等疾病.
使用这些模型进行进一步的研究可以加速开发有效的治疗方法.

关键词:

自自是一种自的过程.疾病模型的疾病模型.在 IPSC 里面,神经退行性疾病是一种神经退行性疾病.

更多相关视频

Conversion of Human Induced Pluripotent Stem Cells iPSCs into Functional Spinal and Cranial Motor Neurons Using PiggyBac Vectors

Conversion of Human Induced Pluripotent Stem Cells iPSCs into Functional Spinal and Cranial Motor Neurons Using PiggyBac Vectors

Published on: May 1, 2019

Robust Tissue Fabrication for Long-Term Culture of iPSC-Derived Brain Organoids for Aging Research

Robust Tissue Fabrication for Long-Term Culture of iPSC-Derived Brain Organoids for Aging Research

Published on: May 12, 2023

相关概念视频

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...